Side effects of calcium channel blockers

Area of Science:

• Pharmacology
• Cardiovascular Medicine

Background:

• Calcium channel blockers (CCBs) are chemically diverse, potentially leading to varied effects.
• Adverse reactions to CCBs can be categorized by pharmacological actions.

Purpose of the Study:

• To review and categorize the adverse effects of calcium channel blocking drugs.
• To highlight differences in adverse reactions among various CCBs.

Main Methods:

• Review of known adverse reactions associated with CCB use.
• Categorization of side effects based on pharmacological mechanisms.

Main Results:

• Vasodilatory symptoms (dizziness, headache) and peripheral edema are common with nifedipine.
• Verapamil and diltiazem exhibit greater negative inotropic and conduction effects than nifedipine.
• Gastrointestinal issues (nausea, constipation) are associated with verapamil; insulin inhibition noted at high doses.

Conclusions:

• CCB adverse effects are largely predictable based on their pharmacological profiles.
• Contraindications include heart block, sick sinus syndrome, and severe heart failure.
• Nifedipine has minimal cardiac conduction effects at therapeutic doses, unlike verapamil and diltiazem.